Insmed (INSM) Enterprise Value (2010 - 2026)

Insmed's Enterprise Value history runs 17 years deep, the most recent figure standing at -$1.2 billion for Q1 2026.

• On a quarterly basis, Enterprise Value fell 2.01% year-over-year to -$1.2 billion in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 2.01% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 billion, changed 0.26% from the prior year.
• Enterprise Value advanced to -$1.2 billion in Q1 2026 per INSM's latest filing, from -$1.4 billion in the prior quarter.
• Across five years, Enterprise Value topped out at -$513.3 million in Q3 2022 and bottomed at -$1.9 billion in Q2 2025.
• The 5-year median for Enterprise Value is -$1.1 billion (2022), against an average of -$1.1 billion.
• Across the five-year window, Enterprise Value surged 40.35% in 2024 and tumbled 101.34% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$1.1 billion in 2022, then jumped by 32.03% to -$780.4 million in 2023, then tumbled by 83.72% to -$1.4 billion in 2024, then rose by 0.26% to -$1.4 billion in 2025, then advanced by 14.44% to -$1.2 billion in 2026.
• Per Business Quant, the three latest INSM Enterprise Value figures stand at -$1.2 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.7 billion (Q3 2025).